Literature DB >> 3982656

Hypomelanosis of Ito: association with a chromosomal abnormality.

C A Miller, W D Parker.   

Abstract

We report the clinical and neuroradiologic findings and the association of a chromosome abnormality, t(2,8), with a case of hypomelanosis of Ito (incontinentia pigmenti achromians). Chromosome anomalies have not been previously recognized in this genetically determined, neurocutaneous disorder.

Entities:  

Mesh：

Year:  1985        PMID： 3982656     DOI： 10.1212/wnl.35.4.607

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

1.  Hypomelanosis of Ito and hemimegalencephaly.

Authors:  P A Battistella; A Peserico; P Bertoli; P Drigo; A M Laverda; G L Casara
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

2.  Asymmetry and skin pigmentary anomalies in chromosome mosaicism.

Authors:  C G Woods; A Bankier; J Curry; L J Sheffield; S F Slaney; K Smith; L Voullaire; D Wellesley
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

3.  Hypomelanosis of ito is frequently associated with autism.

Authors:  Michele Zappella
Journal:  Eur Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 4.785

4.  Unusual brain MRI findings in a patient with hypomelanosis of Ito.

Authors:  V Bhushan; R R Gupta; J Weinreb; R Kairam
Journal:  Pediatr Radiol       Date:  1989

Review 5.  Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature.

Authors:  Komi Assogba; Edoardo Ferlazzo; Pasquale Striano; Tiziana Calarese; Nathalie Villeneuve; Ivan Ivanov; Placido Bramanti; Edoardo Sessa; Iliana Pacheva; Pierre Genton
Journal:  Neurol Sci       Date:  2009-11-10       Impact factor: 3.307

6.  Hypomelanosis of Ito (incontinentia pigmenti achromians) and mosaicism for a microdeletion of 15q1.

Authors:  C Turleau; F Taillard; M Doussau de Bazignan; N Delépine; J C Desbois; J de Grouchy
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.